Clinical Trial

The COLchicine and Atrial FIBrillation Trial

Study acronym: COLFIB
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2024 (before its estimated June 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study to investigate the effects of colchicine on atrial fibrillation recurrence and vascular and cardiac function in patients with atrial fibrillation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-23.
Status change: Not Yet Recruiting → Recruiting 2024-02-27
Trial Details
NCT Number NCT05928728
Lead Sponsor Herlev and Gentofte Hospital
Conditions Atrial Fibrillation
Enrollment 500 participants
Start Date 2023-07-03
Primary Completion 2026-06-14 (estimated)
Study Completion 2028-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-02-28